Work

MA01.05 Efficacy and Safety of Neoadjuvant Camrelizumab and Apatinib Combined with Chemotherapy in Stage IIIA (N2) NSCLC: A Single Arm, Phase II Trial

Year: 2024

Type: article

Study design: Clinical Trial

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2024.09.093

Authors: L. Zhao, W. Chen, T. Guo, Y. Huang, L. Zhu, S. Chen, X. Chen, Y. Zhang, Y. Yang, X. Pan

Institutions: Fujian Medical University, Fujian Provincial Hospital, Fuzhou Pulmonary Hospital of Fujian, Zhangzhou Municipal Hospital of Fujian Province

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4403420034

FWCI:

Cites:

Cited by:

Related to: 10